Clinical trials
Recruiting Multiple Endocrine Neoplasia Type 1 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Arizona State University | 1 |
| National Cancer Institute (NCI) | 1 |
| Sanford Health | 1 |
| Shehzad Basaria, M.D. | 1 |
| St. Jude Children's Research Hospital | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Endocrine Neoplasia Type 1 | 8 |
| Hyperparathyroidism, Primary | 2 |
| Multiple Endocrine Neoplasia Type 2a | 2 |
| Pancreatic Neoplasms | 2 |
| Parathyroid Neoplasms | 2 |
| von Hippel-Lindau Disease | 2 |
| Addison Disease | 1 |
| Adenocarcinoma | 1 |
| Adenomatous Polyposis Coli | 1 |
| Adrenocortical Carcinoma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.